Global 3D Bioprinting Market Share Analysis Forecast 2024 - 2033
1 May, 2024
The 3D bioprinting market has witnessed rapid expansion, escalating from $1.59 billion in 2023 to $1.9 billion in 2024, with a significant CAGR of 19.8%. Historical growth drivers include research and development funding, the rise in chronic diseases and organ shortages, and increased pharmaceutical testing and tissue engineering. Forecasts indicate exponential growth by 2028, reaching $4.15 billion at a CAGR of 21.6%. Anticipated growth catalysts include advancements in healthcare, bioprinted skin development, heightened patient awareness, and an aging population. Key trends include multi-material printing, vascularization techniques, organ-on-a-chip technology, custom implants, and biofabrication in space.
Major Driver In The 3D Bioprinting Market
The expansion of the 3D bioprinting market was fueled by growing government and private funding for research initiatives, exemplified by significant investments such as the European Union's support of $600,000 for Readily3d SA in May 2021 and the Australian Minister for Health's funding of $737,690 to Curtin University in June 2020. These financial injections underscored the commitment to advancing 3D bioprinting techniques, contributing to the market's growth trajectory, as evidenced by market size values for 2023, 2024, and 2028 aligning with this upward trend.
Request A Free Sample Of The Global 3D Bioprinting Market ReportGlobal 3D Bioprinting Market Competitive Landscape
Organovo Holdings Inc., Allevi Inc., Cellink AB, Aspect Biosystems Ltd., 3D Systems Corporation, Cyfuse Biomedical KK, EnvisionTEC GmbH, Poietis SA, TeVido BioDevices, Nano3D Biosciences Inc., Digilab Inc., RegenHU Ltd., GeSiM mbH, Advanced Solutions Life Sciences LLC, Regenovo Biotechnology Co. Ltd., Regemat 3D S.L., Bio3D Technologies, Stratasys Ltd., ROKIT Healthcare Co. Ltd., Inventia Life Science Pvt. Ltd., Vivax Bio LLC, GE HealthCare Technologies Inc., 3D Biotek LLC, Nuclera Nucleics Ltd., 3D Fortify Inc., Carbon Inc., Divergent Technologies Inc., Markforged Inc., SprintRay Inc., 3D Bio Corp, 3D Bioprinting Solutions, BICO Group AB, CollPlant Biotechnologies Ltd., Shining 3D Tech Co. Ltd., 3Dynamic Systems Ltd., Modern Meadow Inc.
Key 3D Bioprinting Market Trend
In the 3D bioprinting market, major companies are introducing cost-effective next-generation bioprinters like the BIO MDX Series to enhance precision. Cognex Corporation launched the BIO MDX Series in March 2021, targeting high-throughput fabrication and precision 3D bioprinting in biomedical manufacturing. This advancement addresses the need for improved automation, precision, and reproducibility in tissue engineering and regenerative medicine.
Get The Full Global 3D Bioprinting Market Report3D Bioprinting Market Segmentation
The global 3d bioprinting market covered in this report is segmented –
1) By Component: 3D Bioprinters, Bioinks
2) By Material: Living Cells, Hydrogels, Extracellular Matrices, Other Materials
3) By Application: Research Applications, Clinical Application, Other Applications
4) By End User: Research Organization And Academic Institutes, Biopharmaceuticals Companies, Hospitals, Other End Users
By Geography:The regions covered in the 3d bioprinting market report include Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
North America was the largest region in the 3D bioprinting market in 2023. The Asia-Pacific is expected to be the fastest-growing region in the 3D bioprinting market during the forecast period.
The 3D Bioprinting Global Market Report 2024 furnishes information about the global 3d bioprinting market, encompassing details like market size, projections for growth, segmentation across various sectors and regions, and an overview of competitors, including their revenues, profiles, and market shares. Furthermore, the report pinpoints potential opportunities and strategic directions derived from market trends and the strategies adopted by key competitors. The report also offers an assessment of how the COVID-19 pandemic, the Russia-Ukraine conflict, and increasing inflation have affected both global and regional markets, furnishing valuable strategic insights for businesses.